HSE Expands Free Home Hepatitis C Testing with Oral Swab in Ireland
Ireland's HSE has expanded its free home hepatitis C testing to include an oral swab, aiming to meet WHO's 2030 elimination targets. The silent virus affects 3,500-5,000 people in Ireland, many unknowingly. Early detection is vital for accessing highly effective antiviral treatments.
The Health Service Executive (HSE) in Ireland has expanded its free, confidential home-testing service for hepatitis C to include an oral swab. This self-test, available to anyone over 18 via hepctest.hse.ie, provides results within 20 minutes and is part of Ireland's strategy to meet the World Health Organisation's (WHO) 2030 elimination targets for the virus.
Hepatitis C is a silent virus, often undetected until it causes severe liver damage like cirrhosis or cancer. An estimated 3,500-5,000 people in Ireland live with chronic hepatitis C, many unaware of their infection. While there is no vaccine, antiviral medications boast a cure rate over 95%. Early detection through testing is crucial for accessing treatment.
The virus is primarily transmitted through blood-to-blood contact, commonly via shared drug injection equipment, non-sterile tattoo/piercing tools, or razors. Unprotected sex, especially among gay, bisexual, and other men who have sex with men, also poses a risk. Since 1991, all blood donations in Ireland have been screened for hepatitis C. A 1995 tribunal has paid over €174 million in compensation for infections from contaminated blood products.
Ireland is a low-prevalence country for hepatitis C, with chronic infections estimated at 0.1% of the population. The national treatment program has treated over 8,000 people with high success rates. Efforts include targeted services for high-risk groups and universal screening for pregnant women, though currently only Dublin's three maternity hospitals offer this routinely. Community-based treatment, initiated by a 2017 pilot, now accounts for 20% of all hepatitis C treatments, making care more accessible.